SPOTLIGHT -
Pfizer Profits Spike as Wyeth Deal is Finalized
The third quarter reports are in, and Pfizer's profits are up but sales are down. The company is compensating for looming patent expirations with layoffs and restructuring; is it enough to boost sales?
